header

Conference Agenda

Wednesday, February 3, 2016  (Patients/Caregivers)

Session Chair: Stacie Lindsey, CCF President & Founder

Because patients living with cholangiocarcinoma have a direct stake in their own medical care and are in a unique position to provide input, CCF has expanded its Annual Conference to include programming that addresses questions and concerns that are important to patients and their families. Patients and caregivers—having experienced the disease firsthand—will be invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further cholangiocarcinoma research.

TIME AGENDA PRESENTERS
10am-Noon Nursing Advisory Board Meeting Invitation Only
Noon-1:00pm Lunch and Networking All Attendees
1:00-1:10pm Welcome to Conference Stacie Lindsey, CCF President and Founder
Dr. Ghassan Abou-Alfa, Memorial Sloan Kettering Cancer Center
1:10-1:40pm Patient Perspective - Navigating the Ups and Downs of the Cancer Journey Melinda Bachini, CCF Patient Advocate
1:40-1:50pm Q&A All Attendees
1:50-2:00pm Mobile App Demonstration Mark Cirillo and Nikki Fonseth, Boston Scientific
2:00-2:15pm What is a Bile Duct? Dr. Renuka Iyer, Roswell Park Cancer Institute
2:15-2:30pm Q&A All Attendees
2:30-3:00pm International CC Patient Registry
CCF Website Overview
Cholangiocarcinoma Foundation
3:00-3:30pm Break and Networking All Attendees
3:30-4:10pm Cholangiocarcinoma Research – Overview, What’s New, Challenges and Gaps Dr. Juan Valle, University of Manchester
4:10-4:30pm Q&A All Attendees
4:30-5:10pm Clinical Trials - Overview of Research Process, Current Studies, Trial Participation, Benefits vs. Risks, Expectations, Results Dr. Kabir Mody, Mayo Clinic
5:10-5:30pm Q&A All Attendees
5:30-6:00pm Open Panel Discussion All Presenters – Moderated by Dr. Ghassan Abou-Alfa, Memorial Sloan Kettering Cancer Center
6:00-7:00pm Dinner and Networking All Attendees
7:00-9:00pm CCF Partners Meeting Invitation Only
7:00-9:00pm Meet & Greet Celebration All Attendees

Portions of this event will be broadcast via live streaming and recorded for post-event viewing via YouTube and the Cholangiocarcinoma Foundation website.

Patients and Caregivers Live Webcast – Wednesday, February 3, 2016, 3:00pm – 8:00pm (Eastern Time)

Register for the Live Webcast

Thursday, February 4, 2016 (Clinical)

Session Chair: Dr. Ghassan Abou-Alfa, Memorial Sloan Kettering Cancer Center

TIME AGENDA PRESENTERS
7:00-8:00am Medical and Scientific Advisory Board Meeting Invitation Only
8:00-8:05am Welcome to the Conference Dr. Robin Kim, Huntsman Cancer Institute
Dr. Ghassan Abou-Alfa, Memorial Sloan Kettering Cancer Center
8:05-8:20am Cholangiocarcinoma Foundation Update Stacie Lindsey, CCF President and Founder
8:20-8:30am Mobile App Demonstration Mark Cirillo and Nikki Fonseth, Boston Scientific
  Molecular Profiling  
8:30-8:50am A Needle in a Haystack Dr. Anthony El-Khoueiry, University of Southern California
8:50-9:10am The Future of Therapy Dr. Maeve Lowery, Memorial Sloan Kettering Cancer Center
9:10-9:15am Rebuttal Dr. Anthony El-Khoueiry, University of Southern California
9:15-9:30am Q&A  
  Global Conference  
9:30-10:30am Fluke-Worm Related Cholangiocarcinoma, The Facts. Dr. Suebpong Tanasanvimon, Chulalongkorn University
10:30-11:00am Break & Networking  
  Adjuvant Therapy Triple Threat  
11:00-11:20am There is no Role for Adjuvant Therapy Dr. Milind Javle, MD Anderson Cancer Center
11:20-11:40am There is a Role for Chemotherapy Dr. Jennifer Knox, Princess Margaret, Toronto
11:40-11:45am And I Add Radiation Therapy Dr. Ted Hong, Massachusetts General Hospital
11:45-Noon Q&A  
Noon-1:00pm Plenary Session I
Immunotherapy. The New Era!
Dr. James Harding, Memorial Sloan Kettering Cancer Center
1:00-2:00pm Lunch and Networking  
  Resection and Transplant Debate  
2:00-2:20pm Extrahepatic CC Should Be Transplanted Dr. William Chapman, Washington University St Louis
2:20-2:40pm Extrahepatic CC Should Be Resected Dr. Michael Choti, University of Texas Southwestern
2:40-2:45pm Rebuttal Dr. William Chapman, Washington University St Louis
2:45-3:00pm Q&A  
  Systemic Therapy Debate  
3:00-3:20pm One Size Fits All Dr. Juan Valle, University of Manchester
3:20-3:40pm Custom-Made Therapy Dr. Katie Kelley, University of California San Francisco
3:40-3:45pm Rebuttal Dr. Juan Valle, University of Manchester
3:45-4:00pm Q&A  
4:00-4:30pm Break & Networking  
4:30-5:00pm Workshop
Moderated by:
Dr. Ghassan Abou-Alfa, Memorial Sloan Kettering Cancer Center
Second Line Chemotherapy in Advanced Biliary Cancer: A Retrospective, Multicenter Analysis of Outcomes Dr. Maeve Lowery, Dr. Laura Goff, Dr. Katie Kelley
Systemic Therapy Towards Splitting
Immunotherapy Strategy
5:30-5:45pm CCF Advocacy Update Marion Schwartz, CCF Chief Advocacy Officer
5:45-5:55pm Patient Presentation Bruce Coppock
5:55-6:00pm Q&A  
6:00-7:00pm Dinner  
7:00-9:00pm Poster Session and 10th Anniversary Celebration  

Friday, February 5, 2016 (Basic-Translational)

Session Chair: Dr. Ben Stanger, University of Pennsylvania

TIME AGENDA PRESENTERS
7:00-8:00am ICRN Meeting Invitation Only
8:00-8:05am Welcome to the Conference Day 3 Dr. Ben Stanger, University of Pennsylvania
8:05-8:15am Patient Presentation Kandice Fogle
8:15-8:20am Q&A  
  Genetics  
8:20-8:45am Molecular Pathways & Therapeutic Opportunities Dr. Greg Gores, Mayo Clinic
8:45-9:10am The Genetic Landscape of CC Dr. Lawrence Kwong, MD Anderson Cancer Center
9:10-9:35am Cell free DNA in the Analysis of Pancreatobiliary Cancers Dr. Andrew Rhim, University of Michigan
9:35-9:50am Q&A  
9:50-10:00am ICRN Update Dr. Milind Javle, ICRN Chair
10:00-10:45am Break & Networking  
  Genetics Meets Epigenetics  
10:45-11:10am Genetics, Epigenetics, and Cancer Metabolism Dr. Matthew Vander Heiden, MIT
11:10-11:35am Chromatin Remodeling and Cancer Dr. Jonathan Whetstine, Harvard University/MGH
11:35-Noon Q&A  
Noon-1:00pm Lunch and Networking  
1:00-3:00pm Presentations by CCF Grant Recipients  
  Determining the Cellular Origins of CC Dr. Allyson Merrell, University of Pennsylvania
  Fibroblast Growth Factor Receptor FGFR Family Gene Aberrations in CC Dr. Katsuyuki Miyabe, Mayo Clinic
  Implementation of Precision Medicine, Approaches in Intrahepatic CC Dr. Daniela Sia, Icahn School of Medicine at Mount Sinai
  A Balancing Act: Dysregulated Differentiation and Proliferation as a Novel Mechanism of CC Formation Dr. Chad Walesky, Harvard/Brigham and Women’s Hospital
  An International Collaborative Design of Clinical Practice Nursing Guidelines for Care of Patients with CCA Susan Acquisto, The Bili Project Foundation Co-Founder; CCF Nursing Advisory Board Chair
3:00-3:50pm Break & Networking  
  Animal Models: Avatars for Therapy  
3:50-4:15pm Liver Cell Plasticity Dr. Holger Willenbring, University of California San Francisco
4:15-4:40pm Targeting CC in Mice Dr. Stuart Forbes, University of Edinburgh
4:40-5:05pm Using the Mouse to Understand Tumor Heterogeneity Dr. Jesper Andersen, University of Copenhagen
5:05-5:30pm Next Generation Models of CC Dr. Nabeel Bardeesy, Harvard University/MGH
5:30-5:45pm Q&A  
5:45-6:15pm Workshop: From Mutation to Translation Interactive Panel & Audience Discussion
What are the most promising targets and how do we get there?
Dr. Lewis Roberts, Mayo Clinic
Dr. Alan Venook, University of California San Francisco
Dr. Andrew Zhu, Harvard University/MGH
Dr. Milind Javle, MD Anderson Cancer Center
6:15-6:25pm Patient Presentation Michael Lax
6:25-6:30pm Q&A  
6:30pm Closing Dr. Ben Stanger, University of Pennsylvania
Donna Mayer, CCF Executive Director
6:30-7:30pm Dinner  
TIME AGENDA PRESENTERS
9:00am-5:00pm CCF Annual Board of Directors Meeting Invitation Only

(as of 1/24/2016)